- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05443061
Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children
April 24, 2025 updated by: Young-Eun Jang, Seoul National University Hospital
Effect of Subcutaneous Nitroglycerin on the Prevention of Radial Artery Occlusion After Radial Artery Catheterization in Pediatric Patients - a Prospective Randomized Controlled Trial
The primary objective of the study is to evaluate the vasodilative effect of subcutaneous nitroglycerin to prevent radial arterial occlusion(RAO) after removal of the radial arterial catheter in pediatric patients.
The hypothesis of this study is that subcutaneous nitroglycerin will decrease the incidence of radial arterial occlusion after radial arterial catheter removal in pediatric patients by increasing the radial artery size.
This is a single-center, double-blind, randomized, placebo-controlled study comparing the effect of subcutaneous nitroglycerin and saline on radial artery cannulation and catheter removal in pediatric patients.
Prior to the procedure, each patient will be randomized into either the control arm, saline, or the study arm, nitroglycerin.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 3 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients undergoing General anesthesia
- Patients in the Intensive care unit
- Arterial cannulation for hemodynamic monitoring, or multiple blood sample
Exclusion Criteria:
- Unstable vital signs, significant arrhythmia or hypotension, Shock
- High risk of peripheral ischemia
- Skin disease, infection, hematoma, recent cannulation at the radial artery
- History of anaphylaxis to nitroglycerin
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nitroglycerin
Nitroglycerin 5mcg/kg (in 0.5cc) is subcutaneously injected before radial artery cannulation and before removal of the radial arterial catheter.
|
Subcutaneous nitroglycerin injection to decrease the incidence of radial arterial occlusion after arterial catheter removal in pediatric patients.
|
|
Active Comparator: Control
Normal saline (0.5cc) is subcutaneously injected before radial artery cannulation and before removal of the radial arterial catheter.
|
Subcutaneous normal saline injection to decrease the incidence of radial arterial occlusion after arterial catheter removal in pediatric patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of radial arterial occlusion (RAO) (%)
Time Frame: After removal of the radial artery catheter (up to 24 hour)
|
RAO is defined as no pulse oximeter wave at the index finger during compression of the ipsilateral ulnar artery.
|
After removal of the radial artery catheter (up to 24 hour)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First attempt success rate (%)
Time Frame: During radial artery cannulation (up to 1 hour)
|
Success at the first skin puncture
|
During radial artery cannulation (up to 1 hour)
|
|
Size of radial artery (mm)
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
Internal diameter of radial artery
|
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
|
depth of radial artery (mm)
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
depth of radial artery from the skin
|
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
|
flow velocity of the radial artery (cm/s)
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
flow velocity of the radial artery measured by Doppler ultrasound
|
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
|
Perfusion index
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
Perfusion index measured by pulse oximeter sensor at the distally located index finger of radial arterial catheterization
|
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
|
|
Overall attempt (number)
Time Frame: During radial artery cannulation (up to 1 hour)
|
Number of attempt of radial artery cannulation
|
During radial artery cannulation (up to 1 hour)
|
|
Overall Procedure time (seconds)
Time Frame: During radial artery cannulation (up to 1 hour)
|
From ultrasound guidance, to Arterial waveform
|
During radial artery cannulation (up to 1 hour)
|
|
Overall success rate (%)
Time Frame: During radial artery cannulation (up to 1 hour)
|
Success within 2 skin puncture and within 10 minutes
|
During radial artery cannulation (up to 1 hour)
|
|
Incidence of posterior wall puncture (%)
Time Frame: During radial artery cannulation (up to 1 hour)
|
Incidence of posterior wall (transfixation technique) puncture during radial arterial catherization
|
During radial artery cannulation (up to 1 hour)
|
|
Number of arteries cannulated
Time Frame: During radial artery cannulation (up to 1 hour)
|
Number of arteries cannulated for peripheral arterial catheterization
|
During radial artery cannulation (up to 1 hour)
|
|
Malfunction of radial artery catheter
Time Frame: After radial artery cannulation assessed during anesthesia (per 24hour, up to 480 hour)
|
Invasive blood pressure monitoring, Sampling (%)
|
After radial artery cannulation assessed during anesthesia (per 24hour, up to 480 hour)
|
|
Complication rate
Time Frame: After radial artery cannulation assessed up to PACU, PICU stay (per 24hour, up to 480 hour)
|
Hematoma, Distal ischemia, Spasm accessed by ultrasound (%)
|
After radial artery cannulation assessed up to PACU, PICU stay (per 24hour, up to 480 hour)
|
|
Duration of radial arterial catherization
Time Frame: After radial artery cannulation assessed during anesthesia (up to 480 hour)
|
Duration of radial arterial catherization (hours, minutes)
|
After radial artery cannulation assessed during anesthesia (up to 480 hour)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Young-Eun Jang, MD, PhD, Clinical assistant professor, Department of anesthesiology and pain medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kim EH, Lee JH, Song IK, Kim JT, Lee WJ, Kim HS. Posterior Tibial Artery as an Alternative to the Radial Artery for Arterial Cannulation Site in Small Children: A Randomized Controlled Study. Anesthesiology. 2017 Sep;127(3):423-431. doi: 10.1097/ALN.0000000000001774.
- Jang YE, Cho SA, Ji SH, Kim EH, Lee JH, Kim HS, Kim JT. Smart Glasses for Radial Arterial Catheterization in Pediatric Patients: A Randomized Clinical Trial. Anesthesiology. 2021 Oct 1;135(4):612-620. doi: 10.1097/ALN.0000000000003914.
- Jang YE, Ji SH, Kim EH, Lee JH, Kim HS, Mossad EB, Kim JT. Subcutaneous Nitroglycerin for Radial Arterial Catheterization in Pediatric Patients: A Randomized Controlled Trial. Anesthesiology. 2020 Jul;133(1):53-63. doi: 10.1097/ALN.0000000000003308.
- Jang YE, Kim EH, Lee JH, Kim HS, Kim JT. Guidewire-assisted vs. direct radial arterial cannulation in neonates and infants: A randomised controlled trial. Eur J Anaesthesiol. 2019 Oct;36(10):738-744. doi: 10.1097/EJA.0000000000001064.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 8, 2022
Primary Completion (Actual)
March 24, 2025
Study Completion (Actual)
March 24, 2025
Study Registration Dates
First Submitted
June 29, 2022
First Submitted That Met QC Criteria
June 29, 2022
First Posted (Actual)
July 5, 2022
Study Record Updates
Last Update Posted (Actual)
April 29, 2025
Last Update Submitted That Met QC Criteria
April 24, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2206-070-1332
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemia
-
University Hospital, Strasbourg, FranceTerminatedVascular Surgery | Ischemia-reperfusion | Ischemia PreconditioningFrance
-
Beytepe Murat Erdi Eker State HospitalCompletedAnterior Segment Ischemia (Diagnosis)
-
University Hospital, Strasbourg, FranceCompletedSkeletal Muscle Ischemia | Severe Lower Limb Ischemia | Mitochondrial DysfunctionFrance
-
The First Affiliated Hospital with Nanjing Medical...RecruitingHepatic IschemiaChina
-
Maastricht University Medical CenterUnknownIschemia-ReperfusionNetherlands
-
Egyptian Cerebro-Cardio-Vascular AssociationUnknownRisk Factor, Cardiovascular | Ischemia, Myocardial | Ischemia, Cerebral
-
Universitätsmedizin MannheimUnknown
-
Fudan UniversityActive, not recruiting
-
Changi General HospitalCompletedCritical Limb IschemiaSingapore
-
AnGes USA, Inc.TerminatedCritical Limb IschemiaUnited States, France, Belgium, Canada, Poland, Finland, Denmark, Netherlands, Hungary, Italy, Sweden
Clinical Trials on Nitroglycerin
-
Assiut UniversityUnknown
-
University of Texas Southwestern Medical CenterUS Department of Veterans AffairsCompletedRectal CancerUnited States
-
Mansoura UniversityCompletedPulmonary Arterial HypertensionEgypt
-
Copenhagen University Hospital, HvidovreCompletedAcute Heart Failure (AHF)Denmark
-
MediQuest TherapeuticsCompletedRaynaud's PhenomenonUnited States
-
University of California, San FranciscoCompletedProlonged Second Stage of LaborUnited States
-
Maastricht Radiation OncologyAnticancer Fund, Belgium; Reliable Cancer TherapiesTerminatedNon Small Cell Lung Cancer (NSCLC)Netherlands
-
Tri-Service General HospitalCompleted
-
Instituto de Cardiologia de Santa CatarinaCompletedInjury of Radial ArteryBrazil
-
Thomas Jefferson UniversityNot yet recruitingArtery; Dilatation